Intravitreal Dexamethasone Implant for Persistent Macular Thickening and Edema After Vitrectomy for Epiretinal Membrane

Summary

This study seeks to evaluate the effect of the intravitreal 0.7mg dexamethasone implant on central macular thickness and visual acuity in those patients with persistent macular edema after pars plana vitrectomy for epiretinal membrane.

Timeline

Start

2016-01-28

Primary completion

2017-09-14

Completion

2017-09-14

Outcome

Outcome not reported

Stopped: “Terminated due to lack of drug efficacy. 2017 study did not show benefit.”

Drugs

Indications